UCL Discovery
UCL home » Library Services » Electronic resources » UCL Discovery

Deregulation of TGF-β Family Ligands in Cancer

Bloxham, Robert David; (2021) Deregulation of TGF-β Family Ligands in Cancer. Doctoral thesis (Ph.D), UCL (University College London). Green open access

[thumbnail of Bloxham_Thesis.pdf]
Preview
Text
Bloxham_Thesis.pdf

Download (9MB) | Preview

Abstract

The study of signalling dynamics is important for understanding how signalling pathways operate in health and disease. Previous work within the lab investigated how cells respond to TGF-β family ligands over time, in terms of pathway activity. Cells treated with TGF-β reach maximal signal induction at one hour which rapidly attenuates to a low-level steady state despite sustained ligand exposure. Additionally, cells become unresponsive to fresh ligand. This suggests that in diseases, including cancer, where there are sustained levels of pathway activity, another ligand may be responsible for signal propagation or there is re-wiring of mechanisms underlying TGF-β signalling dynamics. Further work in the lab demonstrated that reduced expression of components of the ESCRT machinery led to sustained pathway activity in cells exposed to TGF-β. Furthermore, it was shown that CAFs, a cell type in the tumour stroma, produce functional Activin ligand, which may also be responsible for sustained pathway activation. The work in this thesis aimed to investigate whether these two distinct possibilities could explain the sustained TGF-β family pathway activity observed in disease states by answering two questions: 1. Does compromised ESCRT signalling lead to enhanced TGF-β-mediated output? 2. Is CAF-sourced Activin responsible for pathway signal and output, previously ascribed to TGF-? I have demonstrated that compromised ESCRT function leads to an enhanced TGF-β-mediated epithelial-mesenchymal transition through elevated PSMAD signalling. I have also shown that CAFs from the MMTV-PyMT mouse model of breast cancer produce Activin, that is critical for their contractility whilst affecting their proteome and transcriptome. Furthermore, I have developed in vivo experiments to determine the role of CAF-sourced Activin during tumourigenesis.

Type: Thesis (Doctoral)
Qualification: Ph.D
Title: Deregulation of TGF-β Family Ligands in Cancer
Event: UCL (University College London)
Open access status: An open access version is available from UCL Discovery
Language: English
Additional information: Copyright © The Author 2021. Original content in this thesis is licensed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0) Licence (https://creativecommons.org/licenses/by-nc/4.0/). Any third-party copyright material present remains the property of its respective owner(s) and is licensed under its existing terms. Access may initially be restricted at the author’s request.
UCL classification: UCL
UCL > Provost and Vice Provost Offices
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Life Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Life Sciences > Div of Biosciences
URI: https://discovery.ucl.ac.uk/id/eprint/10131483
Downloads since deposit
112Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item